Methyl 1-(5-bromopyridin-2-yl)cyclopropanecarboxylate

Catalog No. :
ACVFKI257
CAS No. :
1335057-99-2
Molecular Formula :
C10H10BrNO2
Molecular Weight :
256.10

IUPAC Name:methyl 1-(5-bromopyridin-2-yl)cyclopropane-1-carboxylate

Methyl 1-(5-bromopyridin-2-yl)cyclopropanecarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$252.00Login to see priceInquiryInquiry
250mg97%$368.00Login to see priceInquiryInquiry
1g97%$891.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 1-(5-bromopyridin-2-yl)cyclopropanecarboxylate
IUPAC Namemethyl 1-(5-bromopyridin-2-yl)cyclopropane-1-carboxylate
MDL No.MFCD25542297
Molecular FormulaC10H10BrNO2
Molecular Weight256.10
SMILESO=C(C1(C2=NC=C(Br)C=C2)CC1)OC
InChI KeyURBRNTSBWONFRE-UHFFFAOYSA-N
SynonymMETHYL 1-(5-BROMOPYRIDIN-2-YL)CYCLOPROPANECARBOXYLATE;Cyclopropanecarboxylic acid, 1-(5-bromo-2-pyridinyl)-, methyl ester;methyl 1-(5-bromopyridin-2-yl)cyclopropane-1-carboxylate
CAS No.1335057-99-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVFKI257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNXUH296 route compound structure diagram
    ACNXUH2961774-47-6 In Stock
  4. Then
  5. ACVFKI257 route product structure diagram
    ACVFKI2571335057-99-2
Inquiry

2. ACVFKI257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVFKI257 route product structure diagram
    ACVFKI2571335057-99-2
Inquiry

Comments (0)